PA Capital’s NEVRO CORP. NVRO Stock Holding History

PA Capital’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,000	Closed	-$250K	–	121
2019 Q1	$250K	Buy	+4,000	New	+$188K	0.22%	96

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PA Capital's NVRO Position: Q2 2019 in Review

PA Capital sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 7,234 shares — an estimated $452K sold.

PA Capital first reported a position in NVRO in Q1 2019 and held it in 1 quarter. The position peaked at $452K in Q1 2019. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

PA Capital reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
PA Capital sold 7,234 NEVRO CORP. shares in Q2 2019, an estimated $452K.
PA Capital first reported a position in NEVRO CORP. in Q1 2019 and held it in 1 quarter.
PA Capital's NEVRO CORP. position peaked at $452K in Q1 2019.
162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on PA Capital's 13F filing for Q2 2019, filed 8 Aug 2019.